GPI
NVO

General Partner Inc’s Novo Nordisk NVO Stock Holding History

General Partner Inc’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.7K Hold
2,080
– – 0.05% 111
2026
Q1 		$76.4K Hold
2,080
– – 0.05% 115
2025
Q4 		$106K Hold
2,080
– – 0.06% 105
2025
Q3 		$115K Hold
2,080
– – 0.06% 104
2025
Q2 		$144K Hold
2,080
– – 0.08% 99
2025
Q1 		$144K Buy
2,080
+1,200
+136% +$99.1K 0.09% 92
2024
Q4 		$75.7K Hold
880
– – 0.05% 115
2024
Q3 		$105K Hold
880
– – 0.07% 99
2024
Q2 		$126K Hold
880
– – 0.08% 94
2024
Q1 		$113K Buy
+880
New +$105K 0.07% 101

Other funds holding NVO

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
VFM
Viking Fund Management Minot, North Dakota $1.12B AUM 44.65% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
ERP
Eldred Rock Partners San Antonio, Texas $465M AUM 48.86% 1-Year Est. Return
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

General Partner Inc's NVO Position: Q2 2026 in Review

General Partner Inc held its Novo Nordisk (NVO) position steady in Q2 2026 at 2,080 shares worth $99.7K. The position accounts for 0.05% of the portfolio, ranked #111.

General Partner Inc first reported a position in NVO in Q1 2024 and has held it in 10 quarters since. The position peaked at $144K in Q1 2025. 205 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • General Partner Inc held 2,080 shares of Novo Nordisk worth $99.7K as of Q2 2026.
  • General Partner Inc left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.05% of General Partner Inc's portfolio in Q2 2026, its #111 holding.
  • General Partner Inc first reported a position in Novo Nordisk in Q1 2024 and has held it in 10 quarters since.
  • General Partner Inc's Novo Nordisk position peaked at $144K in Q1 2025.
  • 205 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on General Partner Inc's 13F filing for Q2 2026, filed 6 Jul 2026.